INFLUENCE OF CALCIUM CHANNELS BLOCKADE ON NEUROLOGICAL DISORDERS EXPRESSION AND MORTALITY RATE OF ANIMALS IN EXPERIMENTAL HEMORRHAGIC STROKE

Authors:

Abstract:

The purpose of the study was to investigate the relationship between the mortality of experimental animals and methods of neurological status studying, behavioural and cognitive disorders in the dynamics of primary and recurrent hemorrhagic stroke and this pathological state pharmacological correction using calcium channel blockers. Two models of local stroke were used in the studies: the model of acute and repeated hemorrhagic stroke. The article analyzes and compares the mortality rates of experimental animals with the use of various methods of studying primary and recurrent hemorrhagic stroke. We studied and analyzed the dynamics of changes in mortality during the study of neurological status, behavioural and cognitive disorders and performed statistical analysis of animal mortality at different stages of the experiment, which correlated with the severity of neurological disorders and depth, dynamics of primary and recurrent hemorrhagic strokes. It was found that animal mortality depends on the method of hemorrhagic stroke reproduction and its reduction correlates with spontaneous partial recovery of impaired motor function and neurological status in the dynamics and is corrected by medication with calcium channel blockers. Authors demonstrated hemorrhagic stroke-induced animal’s mortality dependence on the pathogenetically based pharmacocorrection. The data received might be considered as an experimental background of reasonability of calcium channels blockers effects testing in clinical conditions at hemorrhagic strokes.

Keywords:

primary hemorrhagic stroke recurrent hemorrhagic stroke mortality neurological deficit behavioural changes memory disturbances calcium channel blockade

References:

1. Buresh Ya, Bureshova O, Khyuston DP. Metodiki i osnovnyye eksperimenty po izucheniyu mozga i povedeniya. M: Vysshaya shkola, 1991: 399. [in Russian]
2. Vastyanov RS, Kopyeva NV. Razlichnyye effekty nekotorykh protivosudorozhnykh preparatov v usloviyakh pilokarpin-vyzvannykh spontannykh sudorog. Ukr. Med. Almanakh. 2010; 13(4) :24–26. [in Russian]
3. Zozulya IS, Volosovets AO, Parhomenko BL. Shchodo deyakykh patohenetychnykh mekhanizmiv ishemichnoho insultu v osib molodoho viku. Ukr med chasopys. 2022; 6(152) :1–4 DOI: 10.32471/umj.1680–3051.152.231316. [in Ukrainian]
4. Kirchev VV, Vastyanov RS. Vplyv semaksu ta hopantenovoyi kysloty na lokomotornu aktyvnist ta nevrolohichnyy defitsyt u shchuriv za umov khronichnoyi ishemiyi mozku. Visnyk morskoi medycyny. 2022; 2(95) :107–118. Doi: https://zenodo.org/record/6984233. [in Ukrainian]
5. Kuznetsova SM, Korzhenevskaya NN. Vliyaniye antagonistov kaltsiya na funktsionalnoye sostoyaniye mozga u bolnykh v vosstanovitelnom periode gemorragicheskogo insulta. Zhurnal nevrolohiyi ím. B.M. Mankovskogo. 2014; 2(2) :52–56. [in Russian]
6. Makarenko AN, Morozov SG, Savosko SI, Vasilyeva IG. Modelirovanie povtornogo ochagovogo gemorrgacheskogo insulta u krys. Patol Fiziol Jeksper Ter. 2013;(1) :81–85. [in Russian]
7. Tsimeyko OA, Abbas-zade YeZ, Moroz VV, Skorohoda II, Shahin N. Vazospazm u bolnykh s razryvom arterialnykh anevrizm perednego polukoltsa, oslozhnennykh vnutrimozgovymi i vnutrizheludochkovymi krovoizliyaniyami. Ukr med chasopys. 2011; 2 :98−101. [in Russian]
8. Li J, Lu J, Mi Y, Shi Z, Chen C, Riley J, Zhou C. Voltage-dependent anion channels (VDACs) promote mitophagy to protect neuron from death in an early brain injury following a subarachnoid hemorrhage in rats. Brain Res. 2014; 1573 :74–83. doi: 10.1016/j.brainres.2014.05.021
9. Liu L, Fujimoto M, Kawakita F, Nakano F, Imanaka-Yoshida K, Yoshida T, Suzuki H. Anti-vascular endothelial growth factor treatment suppresses early brain injury after subarachnoid hemorrhage in mice. Mol. Neurobiol. 2016; 53(7) :4529–4538. doi: 10.1007/s12035-015-9386-9.
10. Maida CD, Norrito RL, Daidone M, Tuttolomondo A, Pinto A. Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches. Int J Mol Sci. 2020;21(18) :6454. doi: 10.3390/ijms21186454.
11. Pushko OO, Lytvynenko NV. Peculiarities of neurocognitive status of patients in the acute ischemic stroke phase of different hemispheric localization. World of Medicine and Biology. 2020; 2(72) :99–103. DOI 10.26724/2079-8334-2020-2-72-99-103
12. Sanchez-Bezanilla S, Hood RJ, Collins-Praino LE, Turner RJ, Walker FR, Nilsson M, Ong LK. More than motor impairment: A spatiotemporal analysis of cognitive impairment and associated neuropathological changes following cortical photothrombotic stroke. J Cereb Blood Flow Metab. 2021; 41 (9) :2439–2455. doi: 10.1177/0271678X211005877
13. Surojit P, Eduardo Candelario-Jalil Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies. Exp Neurol. 2021; 335 :113518. doi:10.1016/j.expneurol.2020.113518.
14. Tatuene Kamtchum J, Allali G, Saj A, Bernati T, Sztajzel R, Pollak P, Momjian-Mayor I. Incidence, risk factors and anatomy of peripersonal visuospatial neglect in acute stroke. Eur. Neurol. 2016; 75(3−4) :157−163. doi: 10.1159/000444709
15. Veltkamp R, Pearce LA, Korompoki E, Sharma M, Kasner SE, Toni D et al. Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial. JAMA Neurol. 2020;77(10) :1233–1240. doi: 10.1001/jamaneurol.2020.1995.

Publication:

«World of Medicine and Biology» Vol. 18 No. 81 (2022) , с. 201-206
УДК 616.857: [616.831-073.432.19:616.711.1-073.7]

DOI:

https://doi.org/10.26724/2079-8334-2022-3-81-201-206